The global weight loss and obesity management market is estimated to be valued at US$ 170.0 billion in 2019 and is expected to exhibit a CAGR of 7.1% over the forecast period (2019-2027). Obesity is defined as excess body fat accumulation. The major factors contributing to obesity throughout the world are diseases and the adoption of unhealthy lifestyles.

Different methods used for the management of weight loss and obesity are drugs, dietary supplements, weight loss surgery (bariatric surgery), and exercise. According to the World Health Organization, when the Body-Mass-Index is greater than or equal to 25, the person is categorized as overweight; and a BMI index above 30 is classified as obese.

The increasing prevalence of obesity is expected to propel the market growth

The increasing prevalence of obesity in developed and emerging economies of the world is projected to propel the growth of the market during the forecasted period. For instance, according to reports published by the World Federation of Obesity, roughly 27.4 million children in India will be obese by 2030. This rapid increase in childhood obesity in India is expected to increase demand for weight loss and obesity management techniques during the forecast period.

Furthermore, increasing research and development, and adoption of strategies such as collaborations and the development of novel products by market players to expand their geographical footprint is expected to drive the growth of the weight loss and obesity management market. For instance, in July 2018, Eisai Co., Ltd. entered an agreement to grant exclusive development and marketing rights to CY Biotech for its anti-obesity agent lorcaserin hydrochloride (lorcaserin) in China.

Furthermore, factors such as limited awareness in lower-income countries and the high cost of weight loss and obesity management products & services are expected to hinder the growth of the market during the forecast period.

Global Weight Loss and Obesity Management Market Share (%), by Age Group Type, (2019-2027)

Key Players

Major players operating in the global weight loss and obesity management market include Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, VIVUS Inc., Herbalife Ltd., Apollo Endosurgery (U.S.), Amer Sports, Brunswick Corporation, Cybex International, Duke Products & Services & Fitness Center, Ethicon Inc., Equinox, Inc., Johnson & Johnson Services, Inc., Kellogg Company, Life Time Fitness Inc., Medtronic, and NutriSystem, Inc.

Importance & Scope:

Obesity is a major public health problem worldwide, with the potential to hinder progress toward the SDGs. The only feasible option to combat the crisis is to consider prevention. Unhealthy diets, malnutrition, and sedentary lifestyles are major causes of obesity in children.

Obesity in children is not limited to Europe–it is a global phenomenon. Ending Childhood Obesity urged measures to promote healthy food intake and physical activity, concentrating on early years and environments for children. An estimated 49 million children under 5 years of age were overweight or obese in 2019; almost three-quarters of these children live in Asia and Africa. Preventive measures for obesity must be essential to any effort to stop the worldwide double burden of malnutrition. As such, COSI's country expertise–in producing information and helping countries plan, enforce and review policies–is an important asset for international sharing.

Target Audience:

• Obesity specialists
• Physical Therapists
• Endocrinologists
• Researchers
• Physicians
• Industry Professionals
• Medical Colleges
• Health Promoters
• Public Health Professionals
• Pharmacists
• Drugs & R & D Medical Devices Manufacturing Companies
• Basic Clinical Research Scientists & Students
• Metabolic & Bariatric Surgeons
• Physicians
• Integrated Health Professionals
• Registered Dieticians & Nutritionists
• Yoga & Fitness Professionals
• Obesity & Endocrinology Associations and Societies
• Business Entrepreneurs
• BMI Training Institutes

Related Companies/Industries/Hospitals:

• Obesity Surgery Company- London
• The London Obesity Clinic
• Harley Street Obesity Clinic
• Beckenham Hospital
• Cromwell Hospital
• Greenwich Hospital, London
• Harold Wood Hospital
• Highgate Hospital
• Highgate Private Hospital
• Hospital of St John and St Elizabeth
• Hospitals in Richmond upon Thames
• King Edward VII's Hospital
• Lister Hospital (Chelsea)
• London Bridge Hospital
• London Welbeck Hospital
• North Middlesex Hospital
• Poplar Hospital
• Tite Street Children's Hospital
• Portland Hospital
• The Princess Grace Hospital
• Priory Hospital
• Royal Hospital for Neuro-disability
• St. Anthony's Hospital, North Cheam
• St Luke's Hospital for the Clergy
• St Pancras Hospital
• Scio House Hospital
• Wellington Hospital, London
• Weymouth Street Hospital

Related Associations and Societies:

• British Obesity Society
• World Obesity Federation
• British Obesity & Metabolic Surgery Society
• European Association for the Study of Obesity
• Association for the Study of Obesity
• International association for the study of obesity
• World Obesity Federation
• Global Obesity Prevention Center
• World Health Organisation
• The International Association for the Study of Obesity
• The International Diabetes Federation
• The International Pediatric Association
• The International Union of Nutritional Sciences
• The International Development Research Centre
• Beth Israel Deaconess Medical Center
• Mayo Clinic & Mayo Foundation
• UT South-western Medical Center
• Centre for Obesity Research and Education (CORE)